Millions of people worldwide are currently impacted by heart valve disease, and one in eight people aged 75 and older have the most common form, aortic stenosis (AS). Currently, treatment options for AS include transcatheter aortic valve replacement (TAVR), a minimally invasive procedure, or a surgical aortic valve replacement (SAVR), also known as open heart surgery.
Dr. Purvi Parwani, M.D., Director of the Women’s Cardiovascular Health Clinic at Loma Linda International Heart Institute discusses new findings from a CardioSurve survey, sponsored by Medtronic and conducted by the American College of Cardiology, that reveals more than half of cardiologists believe patient preparation may lead to better quality discussions around treatment options for heart valve disease. However, the survey also uncovered cardiologists feel that their symptomatic severe AS patients are not as informed as they should be about their treatment options. Dr. Parwani will address why shared decision making is critical to individualized care and how to advance patient/physician dialogue.
Purvi Parwani, M.D. currently serves as the director of the Women’s Cardiovascular Health Clinic at Loma Linda International Heart Institute. Dr. Parwani recently sat as a panelist the American College of Cardiology Virtual Symposium and discussed outcomes of the ACC CardioSurve panelist survey. Dr. Parwani graduated from the B.J. Medical College in Ahmedabad and is board certified by the American Board of Internal Medicine, Cardiovascular Disease and American Board of Internal Medicine, Internal Medicine.
Listen on Soundcloud.